Related Experiment Video
Updated: Oct 12, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Improved Alzheimer's Disease Detection by MRI Using Multimodal Machine Learning Algorithms
Gopi Battineni1, Mohmmad Amran Hossain1, Nalini Chintalapudi1
1Telemedicine and Telepharmacy Centre, School of Medicinal and Health Products Sciences, University of Camerino, 62032 Camerino, Italy.
Abstract:
Adult-onset dementia disorders represent a challenge for modern medicine. Alzheimer's disease (AD) represents the most diffused form of adult-onset dementias. For half a century, the diagnosis of AD was based on clinical and exclusion criteria, with an accuracy of 85%, which did not allow for a definitive diagnosis, which could only be confirmed by post-mortem evaluation. Machine learning research applied to Magnetic Resonance Imaging (MRI) techniques can contribute to a faster diagnosis of AD and may contribute to predicting the evolution of the disease. It was also possible to predict individual dementia of older adults with AD screening data and ML classifiers. To predict the AD subject status, the MRI demographic information and pre-existing conditions of the patient can help to enhance the classifier performance. In this work, we proposed a framework based on supervised learning classifiers in the dementia subject categorization as either AD or non-AD based on longitudinal brain MRI features. Six different supervised classifiers are incorporated for the classification of AD subjects and results mentioned that the gradient boosting algorithm outperforms other models with 97.58% of accuracy.
Insights
This study uses machine learning and MRI scans to accurately diagnose Alzheimer's disease (AD) in adults. The gradient boosting algorithm achieved 97.58% accuracy, improving upon traditional diagnostic methods.
Area of Science:
- Neurology
- Medical Imaging
- Artificial Intelligence
Background:
- Alzheimer's disease (AD) is the most common form of adult-onset dementia.
- Traditional AD diagnosis relies on clinical criteria with limited accuracy (85%) and requires post-mortem confirmation.
- Advancements in Magnetic Resonance Imaging (MRI) and machine learning (ML) offer potential for earlier and more accurate AD detection.
Purpose of the Study:
- To develop and evaluate a machine learning framework for classifying Alzheimer's disease (AD) versus non-AD subjects.
- To leverage longitudinal brain MRI features for improved diagnostic accuracy.
- To compare the performance of six supervised learning classifiers for AD detection.
Main Methods:
- A supervised learning framework was implemented using longitudinal brain MRI data.
- Six distinct supervised classification algorithms were employed for AD subject categorization.
- Patient demographic information and pre-existing conditions were considered to enhance classifier performance.
Main Results:
- The gradient boosting algorithm demonstrated superior performance among the evaluated models.
- The proposed framework achieved a high accuracy of 97.58% in classifying AD subjects.
- The study highlights the potential of ML applied to MRI for precise AD diagnosis.
Conclusions:
- Machine learning models, particularly gradient boosting, show significant promise for accurate and early Alzheimer's disease diagnosis using MRI.
- Integrating demographic and clinical data can further enhance the predictive power of ML classifiers for AD.
- This approach offers a non-invasive method to aid in the definitive diagnosis of AD, potentially improving patient management.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...